Page last updated: 2024-10-26

dimaprit and Injury, Ischemia-Reperfusion

dimaprit has been researched along with Injury, Ischemia-Reperfusion in 2 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Research Excerpts

ExcerptRelevanceReference
"The dimaprit treatment depressed the values to 40-64% of those in the corresponding control group 4-24 hr after reperfusion."1.35Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats. ( Adachi, N; Arai, T; Liu, K; Motoki, A; Nagaro, T; Nishibori, M; Takahashi, HK; Yorozuya, T, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, N2
Liu, K2
Motoki, A2
Nishibori, M2
Arai, T2
Takahashi, HK1
Yorozuya, T1
Nagaro, T1

Other Studies

2 other studies available for dimaprit and Injury, Ischemia-Reperfusion

ArticleYear
Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats.
    European journal of pharmacology, 2006, Aug-21, Volume: 544, Issue:1-3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Clozapine; Dimaprit; Dose-Response Relat

2006
Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 102, Issue:4

    Topics: Adenosine Triphosphate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytokines; Dimap

2008